Johnson & Johnson, 2025: J&J's latest sustainability report puts the cumulative mebendazole donation at 2.8 billion doses in more than 70 countries since 2006, with 200 million doses donated in 2025. It is the most recent company-reported scale of the donation programme.
In 2025, we donated 200 million doses of VERMOX Chewable (mebendazole), reaching up to 100 million children and women of reproductive age. Since 2006, J&J has provided 2.8 billion doses in more than 70 countries
p. 2
Johnson & Johnson, 2025: J&J's latest sustainability report puts the cumulative mebendazole donation at 2.8 billion doses in more than 70 countries since 2006, with 200 million doses donated in 2025. It is the most recent company-reported scale of the donation programme. Company self-report (ESG/sustainability reporting), figures as stated by the issuer; not independently audited in the document. Quoted passage is the sidebar text as printed on p. 2, continuous within its column; the PDF's two-column layout makes plain-text extraction split lines, so the verifier should read the sidebar on p. 2 rather than rely on raw text order. Document year 2025 (report title); exact publication month not given on the cover. Study type: other.
